Craft

BioAge

Stock Price

$25.1

2024-10-29

Market Capitalization

$900.8 M

2024-10-29

Revenue

$9 M

FY, 2025

BioAge Summary

Company Summary

Overview
BioAge Labs is a company that develops drugs to treat aging and its related diseases. It leverages human blood samples and related medical records which include disease incidence, frailty, and mortality with a proprietary platform. It explores proprietary and public data to identify and target the molecular factors that influence longevity.
Type
Public
Status
Active
Founded
2015
HQ
Richmond, CA, US | view all locations
Website
https://bioagelabs.com/
Cybersecurity rating
Sectors

Key People

  • Kristen Fortney

    Kristen Fortney, Co-Founder, CEO & Board Member

  • Eric Morgen

    Eric Morgen, Co-Founder, COO & Board Member

  • Robert Hughes

    Robert Hughes, Vice President, Biochemistry

  • Dov Goldstein

    Dov Goldstein, Chief Financial Officer

    LocationsView all

    1 location detected

    • Richmond, CA HQ

      United States

      1445A S 50th St

    BioAge Financials

    Summary Financials

    Revenue (Q1, 2026)
    $2.8M
    Net income (Q1, 2026)
    ($22.3M)
    Cash (Q1, 2026)
    $241.8M
    EBIT (Q1, 2026)
    ($25.4M)
    Enterprise value
    $663.1M

    Footer menu